This site is intended for Healthcare Professionals only.

Leo Pharma appoints Leanne Walsh as General Manager and Vice President for UK and Ireland

Date:

Share post:

Leo Pharma, one of the leaders in medical dermatology, has appointed Leanne Walsh as the new General Manager and Vice President for Leo Pharma United Kingdom and Ireland. 

Leanne joins from Aimmune Therapeutics where she was previously General Manager for Northern Europe.

She has over 20 years of experience in the pharmaceutical industry bringing innovation to patients at Global, European and affiliate level. She is passionate about patients, with expertise in building teams and access capabilities to drive successful commercialisation. She has a strong record of leading launches of life changing therapies in both competitive spaces and in complex, niche, specialist markets where she has demonstrated continued excellence to diagnose, improve and implement brand performance through marketing and selling excellence.

Discussing her appointment, Leanne commented,” I am excited to join the Leo Pharma UK and Ireland team. I firmly believe that Leo Pharma has the opportunity to be the preferred dermatology care partner and can exceed the expectations of both our partners and patients through transformation, dedication and a true partnership approach with all our stakeholders.

My key priorities in this role are to drive proactive innovation and nurture an inclusive work environment where all internal and external stakeholders are inspired to take action to improve the lives of those living with skin conditions. The medical dermatology industry is evolving rapidly, which presents real opportunities for Leo Pharma, and I look forward to the exciting journey ahead.” Leanne will start this role at Leo Pharma United Kingdom and Ireland on the 12th of June 2023.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

ABPI: Increased pharma exports could boost GDP by £16.3 billion

ABPI urges political leaders to enhance healthcare and economic growth through strategic partnership The Association of the British Pharmaceutical...

The Importance Of Expanding Access To Dental Care For Rural And Undeserved Populations

In many rural areas and underserved neighborhoods, a critical issue is quietly emerging. Although often overlooked, its effects...

BGMA: More than 50% of UK generics face shortages without licensed alternatives

Brexit blamed by BGMA CE, Mark Samuels, as UK faces critical shortages in generic drug supply A recent report...

Paul Burden elected BGMA Vice-Chair, bringing 25 years of industry leadership

Veteran of off-patent sector to drive strategic engagement and patient access initiatives at BGMA The British Generic Manufacturers Association...